Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$4.12M Buy
50,253
+2,500
+5% +$197K 0.15% 138
2021
Q4
$3.66M Sell
47,753
-607
-1% -$48.3K 0.12% 149
2021
Q3
$3.63M Buy
48,360
+2,618
+6% +$199K 0.12% 139
2021
Q2
$3.56M Sell
45,742
-813
-2% -$60.5K 0.12% 138
2021
Q1
$3.42M Sell
46,555
-16,378
-26% -$1.21M 0.12% 134
2020
Q4
$4.91M Buy
62,933
+17,403
+38% +$1.33M 0.18% 79
2020
Q3
$3.6M Buy
45,530
+11,750
+35% +$920K 0.15% 91
2020
Q2
$2.49M Buy
33,780
+5,961
+21% +$449K 0.11% 127
2020
Q1
$2.04M Buy
27,819
+26,887
+2,885% +$2.11M 0.1% 99
2019
Q4
$81K Buy
+932
New +$76.6K ﹤0.01% 525

Other funds holding MRK

IndexIQ Advisors's MRK Position: Q1 2022 in Review

IndexIQ Advisors increased its Merck (MRK) stake by 5.2% in Q1 2022, buying an estimated $197K and bringing the position to 50,253 shares worth $4.12M. The position accounts for 0.15% of the portfolio, ranked #138.

IndexIQ Advisors first reported a position in MRK in Q4 2019 and has held it in 10 quarters since. The position peaked at $4.91M in Q4 2020. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • IndexIQ Advisors held 50,253 shares of Merck worth $4.12M as of Q1 2022.
  • IndexIQ Advisors bought 2,500 Merck shares in Q1 2022, an estimated $197K.
  • Merck made up 0.15% of IndexIQ Advisors's portfolio in Q1 2022, its #138 holding.
  • IndexIQ Advisors first reported a position in Merck in Q4 2019 and has held it in 10 quarters since.
  • IndexIQ Advisors's Merck position peaked at $4.91M in Q4 2020.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.